Provectus Biopharmaceuticals to Present at 2015 BIO International Convention … – Digital Journal
Provectus Biopharmaceuticals to Present at 2015 BIO International Convention …Digital JournalPH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for …and more »
[monetize id=”1″]
[monetize id=”2″]
Atopic Dermatitis NYC – (212) 644-6454 – NYC Atopic …
Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic … – MarketWatch
Wall Street PitOculus Innovative Sciences Receives FDA Clearance for Novel Atopic …MarketWatchThe exact cause is unknown, but genetics are considered a key factor. Topical corticosteroids (such as hydrocortisone, betamethasone, and fluticasone) are the most common treatment for atopic dermatitis. As eczema tends to be persistent, most people …Oculus Gets FDA Clearance For Novel Atopic Dermatitis Dermatology ProductRTT NewsOculus Innovative Sciences (OCLS) Announces FDA Clearance for Alevicyn SG …StreetInsider.comUS FDA grants 510(k) clearance to Oculus' new atopic dermatitis dermatology …pharmabiz.comall 21 news articles »
